Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer

doi:10.4251/wjgo.v17.i2.97858

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (588)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-3) series.

Item

Count

PDF

HTML

332

Figures (1-7)

Tables (1-3)

Sum=491

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=73

Feb 15, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Feb 15, 2025; 17(2): 97858
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.97858

Full Size Figure Download Figure

Figure 2 Immune checkpoints showing the most significant differences between high and low colony-stimulating factor 3 expression groups. A: Leukocyte immunoglobulin-like receptor B2; B: Hepatitis A virus cellular receptor 2; C: Chemokine receptor 2; D: CD80; E: Inducible T-cell costimulator; F: CD28. ^dP < 0.0001.

Citation: Wang L, Wu Q, Zhang ZW, Zhang H, Jin H, Zhou XL, Liu JY, Li D, Liu Y, Fan ZS. Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer. World J Gastrointest Oncol 2025; 17(2): 97858
URL: https://www.wjgnet.com/1948-5204/full/v17/i2/97858.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.97858